Published in J Pharmacol Exp Ther on June 01, 1981
Dystonic reactions and the pharmacokinetics of metoclopramide in children. Br J Clin Pharmacol (1983) 0.82
A randomised controlled trial of the effect of continuous electronic physiological monitoring on the adverse event rate in high risk medical and surgical patients. Anaesthesia (2006) 1.63
The efficacy of cefuroxime for the treatment of acute gonorrhoea in men. Br J Vener Dis (1978) 1.41
Should patients choose their anaesthetic? Br Dent J (1990) 1.41
Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol (2006) 1.35
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res (2001) 1.18
Deep wound infection after proximal femoral fracture: consequences and costs. J Hosp Infect (2006) 1.15
A safer method of dilating oesophageal strictures. Lancet (1974) 1.10
Amoxycillin in the treatment of gonorrhoea. Br J Vener Dis (1975) 1.08
Oral talampicillin in the treatment of gonorrhoea. Br J Vener Dis (1977) 1.02
Results of 12 years' treatment of chronic renal failure by dialysis and transplantation. Can Med Assoc J (1978) 0.99
Pharmacokinetic and clinical studies on cefuroxime. Proc R Soc Med (1977) 0.98
Dose response evaluation of cefuroxime in the treatment of gonorrhœa in male and female patients. Proc R Soc Med (1977) 0.92
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Serum and urine osmolalities in the differential diagnosis of polyuric states. J Clin Endocrinol Metab (1966) 0.91
Biopsychosocial aspects of long-term survival on end-stage renal failure therapy. Psychol Med (1989) 0.91
The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci (2001) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
In vitro protein binding of propafenone and 5-hydroxypropafenone in serum, in solutions of isolated serum proteins, and to red blood cells. J Pharm Sci (1992) 0.89
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
Broad or narrow spectrum therapy? Studies with ampicillin and azidocillin in acute chest infections. Scand J Infect Dis (1973) 0.88
Glomerulonephritis: a review based on 52 renal biopsies. Can Med Assoc J (1966) 0.87
Ethnopharmacology of rhinoceros horn. I: Antipyretic effects of rhinoceros horn and other animal horns. J Ethnopharmacol (1990) 0.86
Physiologic surface-active agents and drug absorption. 8. Effect of bile flow on sulfadiazine absorption in the rat. J Pharm Sci (1971) 0.84
Griseofulvin---phenobarbital interaction: a formulation-dependent phenomenon. J Pharm Sci (1978) 0.84
Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82
Phylogenetic relationships and evolutionary history of the shrimp genus Penaeus s.l. derived from mitochondrial DNA. Mol Phylogenet Evol (2004) 0.82
Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg (1998) 0.82
Ethnopharmacology of rhinoceros horn. II: Antipyretic effects of prescriptions containing rhinoceros horn or water buffalo horn. J Ethnopharmacol (1991) 0.82
Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response. J Clin Pharmacol (1998) 0.82
Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clin Pharmacol Ther (1986) 0.81
Flucloxacillin in the treatment of infectious conditions in children. Curr Med Res Opin (1975) 0.81
Medullary cystic disease with macular degeneration. Can Med Assoc J (1970) 0.81
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers. Eur J Clin Pharmacol (1996) 0.81
Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol (1999) 0.81
Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection. J Chromatogr (1984) 0.80
Candida glabrata (syn. Torulopsis glabrata) associated with a chronic hyperplastic lesion of the palate. Br J Oral Maxillofac Surg (1985) 0.80
Linearity of metoclopramide kinetics at doses of 5-20 mg. Br J Clin Pharmacol (1988) 0.80
Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy. Am J Med (1979) 0.80
Reassessing models of hepatic extraction. J Biol Phys (2003) 0.79
Applicability of capillary gas liquid chromatography to the measurement of free fraction of disopyramide in human plasma. Res Commun Chem Pathol Pharmacol (1985) 0.79
Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase. Clin Pharmacol Ther (1980) 0.79
An interactive computer program for determining areas bounded by drug concentration curves using lagrange interpolation. J Pharmacol Toxicol Methods (1995) 0.79
The use of amoxycillin in treatment of urinary tract infection in general practice. Br J Clin Pract (1973) 0.79
Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther (1977) 0.79
Temocillin elimination in patients with varying degrees of renal failure. J Antimicrob Chemother (1983) 0.79
Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79
Food increases the bioavailability of propafenone. Br J Clin Pharmacol (1987) 0.79
Drug disposition and effects in the fetus. J Dev Physiol (1991) 0.79
The pharmacokinetics of captopril in infants with congestive heart failure. Ther Drug Monit (1991) 0.79
Determination of diphenhydramine in biological fluids by capillary gas chromatography using nitrogen-phosphorus detection. Application to placental transfer studies in pregnant sheep. J Chromatogr (1986) 0.79
Simultaneous analysis of diphenhydramine and a stable isotope analog (2H10)diphenhydramine using capillary gas chromatography with mass selective detection in biological fluids from chronically instrumented pregnant ewes. Biol Mass Spectrom (1993) 0.79
Osmotic load from glucose polymers. JPEN J Parenter Enteral Nutr (1991) 0.78
Models of hepatic drug elimination. Drug Metab Rev (1992) 0.78
Nonlinear pharmacokinetics of mibefradil in the dog. J Pharm Sci (1996) 0.78
Estimation of transplacental and nonplacental diphenhydramine clearances in the fetal lamb: the impact of fetal first-pass hepatic drug uptake. J Pharmacol Exp Ther (1997) 0.78
Spurious hypocalcemia in hemodialysis patients after heparinization. In-vitro formation of calcium soaps. Am J Clin Pathol (1979) 0.78
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure. Br J Clin Pharmacol (1988) 0.78
Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration. J Pharmacol Exp Ther (1993) 0.77
In vitro protein binding of propafenone in normal and uraemic human sera. Eur J Clin Pharmacol (1989) 0.77
Determination of ritodrine in biological fluids of the pregnant sheep by fused-silica capillary gas chromatography using electron-capture detection. J Chromatogr (1991) 0.77
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med (2001) 0.77
Time-frequency analysis of the ECG in the diagnosis of vasovagal syndrome in older people. Conf Proc IEEE Eng Med Biol Soc (2004) 0.77
Renal function during cefuroxime treatment in patients with pre-existing renal impairment. J Antimicrob Chemother (1980) 0.77
Propafenone for prevention of recurrent atrial fibrillation. Am J Cardiol (1988) 0.77
Benign lymphoepithelial lesion in a patient with Sjögren's disease and an IgG paraprotein. J Oral Pathol (1983) 0.77
Simplified determination of captopril in plasma by high-performance liquid chromatography. J Chromatogr (1988) 0.77
Placental transport of metoclopramide: assessment of maternal and neonatal effects. Can Anaesth Soc J (1983) 0.76
Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. Drug Metab Dispos (1996) 0.76
Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry (1993) 0.76
Clinical pharmacokinetics of 123I-IAZA in healthy volunteers. Nucl Med Commun (1999) 0.76
Effect of pH-adjustment of bupivacaine on onset and duration of epidural analgesia in parturients. Can Anaesth Soc J (1986) 0.75
Decision-making in the dialysis program in British Columbia: patient selection and allocation. Can Med Assoc J (1971) 0.75
Acute manganese intoxication and pancreatitis in a patient treated with a contaminated dialysate. Can Med Assoc J (1982) 0.75
Liver cysts in end-stage uremia due to polycystic kidney disease. Can Med Assoc J (1970) 0.75
Cefuroxime in chronic and acute cystitis. Proc R Soc Med (1977) 0.75
Glomerulonephritis. Can Med Assoc J (1966) 0.75
Renal osteodystrophy during hemodialysis for chronic renal failure. Can Med Assoc J (1968) 0.75
Hydralazine pharmacokinetics and interaction with food: an evaluation of the dog as an animal model. Pharm Res (1990) 0.75
Tocainide protein binding in normal volunteers and trauma patients. Br J Clin Pharmacol (1982) 0.75
Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex. Eur J Pharmacol (1991) 0.75
'Radiopaque substances in denture manufacture'. Br Dent J (1991) 0.75
Disopyramide pharmacokinetics and metabolism: effect of inducers. Br J Clin Pharmacol (1987) 0.75
More support for fluoridation. Br Dent J (1988) 0.75
An emergency dental service. J Dent (1979) 0.75
Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects. Eur J Clin Pharmacol (1990) 0.75
Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adults. Clin Nephrol (1979) 0.75